Latest Advances

  • Condition: Intermediate-Risk Acute Myeloid Leukemia
  • Journal: Annals of hematology
  • Treatment Used: Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
  • Number of Patients: 127
  • Published —
This study tested the safety and efficacy of using allo-HSCT to treat patients with intermediate-risk acute myeloid leukemia.
  • Condition: Acute Monocytic Leukemia
  • Journal: Zhongguo shi yan xue ye xue za zhi
  • Treatment Used: Allogeneic Hematopoietic Stem Cell Transplantation
  • Number of Patients: 71
  • Published —
The study researched the outcomes of allogeneic hematopoietic stem cell transplantation for treating acute monocytic leukemia.
  • Condition: Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
  • Journal: Hematology (Amsterdam, Netherlands)
  • Treatment Used: Venetoclax (VEN) in Combination with Hypomethylating Agents (HMAs)
  • Number of Patients: 1059
  • Published —
This study evaluated the effectiveness and adverse effects of venetoclax (VEN) in combination with hypomethylating agents (HMAs) in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
  • Condition: Myeloid Leukemia with Down Syndrome (ML-DS)
  • Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
  • Treatment Used: Chemotherapy
  • Number of Patients: 0
  • Published —
This article discusses the treatment strategy for patients wit myeloid leukemia with Down syndrome (ML-DS).
  • Condition: Elderly Patients with Acute Myeloid Leukemia (AML)
  • Journal: Zhongguo shi yan xue ye xue za zhi
  • Treatment Used: Low-Intensity Traditional Chemotherapy
  • Number of Patients: 67
  • Published —
This study investigated the effectiveness of low-intensity traditional chemotherapy for elderly patients with acute myeloid leukemia (cancer of the blood and bone marrow; AML).
  • Condition: Senile Patients with High-Risk Acute Myeloid Leukemia (AML)
  • Journal: Zhongguo shi yan xue ye xue za zhi
  • Treatment Used: Decitabine Combined with Reduced FLAG Regimen
  • Number of Patients: 12
  • Published —
This study evaluated the effectiveness and adverse reactions of decitabine combined with reduced FLAG regimen in senile (loss of cognitive abilities associated with old age) patients with high-risk acute myeloid leukemia (type of blood cancer; AML).
  • Condition: Clostridioides Difficile Infections (CDI) in Patients with Acute Myeloid Leukemia (AML) Undergoing Intensive Induction Chemotherapy
  • Journal: Annals of hematology
  • Treatment Used: Carbapenems and Glycopeptides
  • Number of Patients: 415
  • Published —
This study analyzed the incidence of Clostridioides difficile infections (CDI) in patients with acute myeloid leukemia (AML) undergoing intensive induction chemotherapy.
  • Condition: Acute Myeloid Leukemia
  • Journal: The Lancet. Haematology
  • Treatment Used: 10-day Decitabine with Venetoclax
  • Number of Patients: 168
  • Published —
The study researched the safety and effectiveness of 10-day decitabine with venetoclax for acute myeloid leukemia.
  • Condition: Relapsed Acute Myeloid Leukemia
  • Journal: Medicine
  • Treatment Used: Gemtuzumab Ozogamicin Monotherapy before Stem Cell Infusion
  • Number of Patients: 1
  • Published —
This case report describes a patient with relapsed acute myeloid leukemia that was treated using a gemtuzumab ozogamicin monotherapy before undergoing a stem cell infusion.
  • Condition: Acute Myeloid Leukemia
  • Journal: Nature communications
  • Treatment Used: Chlorpromazine
  • Number of Patients: 0
  • Published —
The study researched the outcomes of chlorpromazine in patients with acute myeloid leukemia.
  • Condition: Acute Myeloid Leukemia
  • Journal: Annals of hematology
  • Treatment Used: Hypomethylating Agents
  • Number of Patients: 110
  • Published —
This study tested the safety and efficacy of using hypomethylating agents to treat patients with acute myeloid leukemia.
  • Condition: Acute Myeloid Leukemia
  • Journal: The New England journal of medicine
  • Treatment Used: Azacitidine with Venetoclax
  • Number of Patients: 431
  • Published —
In this study, researchers evaluated the effectiveness of azacitidine with venetoclax for the treatment of acute myeloid leukemia in persons over 75.
Showing 1-12 of 313